Application challenges of the new EU Clinical Trials Regulation

被引：0
|
作者：
Eugenijus Gefenas
Asta Cekanauskaite
Jurate Lekstutiene
Vilma Lukaseviciene
机构：
[1] Medical Faculty of Vilnius University,Department of Medical History and Ethics
[2] Lithuanian Bioethics Committee,undefined
来源：
European Journal of Clinical Pharmacology | 2017年 / 73卷
关键词：
Research ethics; Ethics committees; Clinical drug trials; Clinical Trials Regulation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：795 / 798
页数：3
相关论文
共 50 条
  • [31] Input analysis for two public consultations on the EU Clinical Trials Regulation
    Holger Langhof
    Jonas Lander
    Daniel Strech
    Health Research Policy and Systems, 14
  • [32] Input analysis for two public consultations on the EU Clinical Trials Regulation
    Langhof, Holger
    Lander, Jonas
    Strech, Daniel
    HEALTH RESEARCH POLICY AND SYSTEMS, 2016, 14
  • [33] New European clinical trials regulation is published
    Mayor, Susan
    LANCET ONCOLOGY, 2014, 15 (08): : 792 - 792
  • [34] Navigating EU clinical trials: Adapting to a new era of regulations
    Kromar, Stephanie
    Kassas, Rana
    JOURNAL OF CANCER POLICY, 2025, 43
  • [35] Clinical trials for predictive medicine: new challenges and paradigms
    Simon, Richard
    CLINICAL TRIALS, 2010, 7 (05) : 516 - 524
  • [36] Multiple sclerosis clinical trials: Old and new challenges
    Noseworthy, JH
    SEMINARS IN NEUROLOGY, 1998, 18 (03) : 377 - 388
  • [37] An EU Comparative Analysis of the Regulation of Clinical Trials Supervisory Bodies in the Aftermath of Regulation 536/2014
    de Miguel Beriain, Inigo
    Chortara, Theodora
    Duardo-Sanchez, Aliuska
    Feeney, Oliver
    Felzmann, Heike
    Fernandez de Uzquiano, Emma
    Lievevrouw, Elisa
    Marelli, Luca
    Mattsson, Titti
    Herrmann, Janne Rothmar
    Minssen, Timo
    Pulice, Elisabetta
    Raposo, Vera Lucia
    Robienski, Jurgen
    Penasa, Simone
    Van Hoyweghen, Inc
    EUROPEAN PUBLIC LAW, 2020, 26 (02): : 307 - 329
  • [38] A review on exosomes application in clinical trials: perspective, questions, and challenges
    Jafar Rezaie
    Maryam Feghhi
    Tahereh Etemadi
    Cell Communication and Signaling, 20
  • [39] A review on exosomes application in clinical trials: perspective, questions, and challenges
    Rezaie, Jafar
    Feghhi, Maryam
    Etemadi, Tahereh
    CELL COMMUNICATION AND SIGNALING, 2022, 20 (01)
  • [40] Phase I studies in EU: due change in compliance and transparency under the EU clinical trials regulation
    Christian Martin De Mey
    European Journal of Clinical Pharmacology, 2022, 78 : 1047 - 1048
12345